Barclays
SGEN

Barclays’s Seagen Inc. Common Stock SGEN Stock Holding History

Barclays’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,300
Closed -$1.07M – 6404
2020
Q1 		$1.07M Sell
9,300
-22,100
-70% -$2.45M ﹤0.01% 2884
2019
Q4 		$3.59M Buy
31,400
+21,600
+220% +$2.29M ﹤0.01% 2374
2019
Q3 		$837K Buy
9,800
+5,600
+133% +$411K ﹤0.01% 3824
2019
Q2 		$291K Buy
4,200
+600
+17% +$42K ﹤0.01% 4785
2019
Q1 		$264K Sell
3,600
-1,000
-22% -$71.2K ﹤0.01% 4617
2018
Q4 		$261K Sell
4,600
-35,100
-88% -$2.2M ﹤0.01% 4390
2018
Q3 		$3.06M Buy
39,700
+30,100
+314% +$2.22M ﹤0.01% 2379
2018
Q2 		$637K Buy
9,600
+3,500
+57% +$200K ﹤0.01% 3714
2018
Q1 		$319K Buy
6,100
+900
+17% +$49K ﹤0.01% 4410
2017
Q4 		$278K Sell
5,200
-30,300
-85% -$1.77M ﹤0.01% 4405
2017
Q3 		$1.93M Buy
35,500
+900
+3% +$46.1K ﹤0.01% 2395
2017
Q2 		$1.79M Buy
34,600
+200
+0.6% +$12.7K ﹤0.01% 2358
2017
Q1 		$2.16M Buy
34,400
+32,300
+1,538% +$2.02M ﹤0.01% 2019
2016
Q4 		$111K Buy
2,100
+700
+50% +$42.1K ﹤0.01% 4675
2016
Q3 		$76K Sell
1,400
-600
-30% -$28.5K ﹤0.01% 4703
2016
Q2 		$81K Sell
2,000
-19,300
-91% -$734K ﹤0.01% 4541
2016
Q1 		$746K Sell
21,300
-84,200
-80% -$2.83M ﹤0.01% 2782
2015
Q4 		$4.64M Buy
105,500
+47,700
+83% +$1.99M 0.01% 1370
2015
Q3 		$2.2M Sell
57,800
-36,800
-39% -$1.66M ﹤0.01% 2043
2015
Q2 		$4.54M Buy
94,600
+7,400
+8% +$305K 0.01% 1561
2015
Q1 		$3.05M Sell
87,200
-67,300
-44% -$2.3M ﹤0.01% 1946
2014
Q4 		$4.94M Buy
154,500
+129,500
+518% +$4.51M ﹤0.01% 1716
2014
Q3 		$925K Buy
25,000
+13,000
+108% +$511K ﹤0.01% 3431
2014
Q2 		$456K Sell
12,000
-34,800
-74% -$1.32M ﹤0.01% 4071
2014
Q1 		$2.11M Sell
46,800
-60,500
-56% -$2.89M ﹤0.01% 2493
2013
Q4 		$4.18M Sell
107,300
-30,600
-22% -$1.25M ﹤0.01% 1977
2013
Q3 		$5.93M Sell
137,900
-430,300
-76% -$17.9M 0.01% 1546
2013
Q2 		$17.9M Buy
+568,200
New +$19.8M 0.02% 704

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Barclays's SGEN Position: Q4 2023 in Review

Barclays sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,779,070 shares — an estimated $377M sold.

Barclays first reported a position in SGEN in Q2 2013 and held it in 37 quarters. The position peaked at $398M in Q2 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Barclays reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 1,779,070 Seagen Inc. Common Stock shares in Q4 2023, an estimated $377M.
  • Barclays first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 37 quarters.
  • Barclays's Seagen Inc. Common Stock position peaked at $398M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.